Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS Gains 11%; BSE HEALTHCARE Index Up 0.8%
Wed, 31 Jul 10:52

SUVEN PHARMACEUTICALS Gains 11%; BSE HEALTHCARE Index Up 0.8%Image source: ipopba/www.istockphoto.com

SUVEN PHARMACEUTICALS share price has zoomed 11% and is presently trading at Rs 1,047.8.

Meanwhile, the BSE HEALTHCARE index is at 40,491.0 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are GRANULES INDIA (up 5.3%) and Jubilant Pharmova (up 4.6%).

POLY MEDICURE (down 1.8%) and J.B.Chemicals (down 1.5%) are among the top losers today.

Over the last one year, SUVEN PHARMACEUTICALS has moved up from Rs 495.0 to Rs 1,047.8, registering a gain of Rs 552.8 (up 111.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,491.0, registering a gain of 46.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 111.7%), Jubilant Pharmova (up 103.5%) and GSK Pharma (up 98.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,732.1 (up 0.3%).

The top gainers among the BSE Sensex today are Asian Paints (up 2.7%) and JSW Steel (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,937.8 (up 0.3%). Asian Paints and NTPC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,732.1, registering a gain of 15,204.4 points (up 22.9%).

SUVEN PHARMACEUTICALS Financial Update...

SUVEN PHARMACEUTICALS net profit fell 56.9% YoY to Rs 534 million for the quarter ended March 2024, compared to a profit of Rs 1,240 million a year ago. Net sales declined 31.5% to Rs 2,529 million during the period as against Rs 3,694 million in January-March 2023.

For the year ended March 2024, SUVEN PHARMACEUTICALS reported 27.0% decrease in net profit to Rs 3,003 million compared to net profit of Rs 4,113 million during FY23. Revenue of the company fell 21.6% to Rs 10,514 million during FY24.

The current Price to earnings ratio of SUVEN PHARMACEUTICALS, based on rolling 12 month earnings, stands at 88.8.


Equitymaster requests your view! Post a comment on "SUVEN PHARMACEUTICALS Gains 11%; BSE HEALTHCARE Index Up 0.8%". Click here!